Dipna Pharmachem Ltd (DPL) is currently trading at 4.26 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Dipna Pharmachem Limited is a Gujarat-based trader, importer and exporter of industrial chemicals and pharmaceutical active ingredients (APIs) and intermediates, operating pan-India since 2011 and trading a portfolio of about 61 APIs across therapeutic segments including cephalosporins, cardiovascular, antiviral and steroid intermediates. In FY2026 Dipna Pharmachem delivered total standalone revenue of Rs. 12,910.87 lakhs (approximately Rs. 129.1 crore) and net profit of Rs. 263.19 lakhs, marking modest profitability while transitioning to IND AS for the first time and receiving an unmodified audit opinion from its statutory auditors. The company raised material equity-linked capital in FY2026: proceeds include Rs. 1,827.01 lakhs from convertible warrants and Rs. 224.39 lakhs of fresh equity, and these financings funded large increases in inventories and other current assets, indicating reliance on shareholder capital to support working capital expansion during the year. Segment disclosure shows a bifurcated business: the Chemicals segment posted a loss for the year while the Steel segment generated substantial profit, meaning Dipna Pharmachem's consolidated results in FY2026 were driven by the steel trading/activities rather than the chemicals/APIs vertical, revealing portfolio concentration risk.

Over the past 52 weeks, Dipna Pharmachem Ltd has traded between a low of ₹3.62 and a high of ₹19.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Dipna Pharmachem Ltd has a market capitalization of approximately 11.20. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Dipna Pharmachem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 5.14 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 11.20 Cr, Dipna Pharmachem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Dipna Pharmachem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Dipna Pharmachem Ltd is 5.14. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.